RBM25 and leukemia: In leukemia, downregulation of RBM25 allows premalignant or malignant cells to harvest the pro-proliferative benefits of MYC (via expression of the BIN(+12) isoform), while at the same time escaping apoptosis (via a shift towards the anti-apoptotic BCL-XL).